Investing.com - Financial Markets Worldwide
Open in App

Samik Pharm Co Ltd (014950)

KOSDAQ
Currency in KRW
8,750
-30(-0.34%)
Closed·

014950 Income Statement

Period Ending:
2023
31/12
2024
31/12
2025
31/12
Total Revenues
51,228.9855,857.3760,020.41
Total Revenues Growth
-+9.03%+7.45%
Cost Of Revenues
17,359.317,119.4217,722.37
Gross Profit
33,869.6838,737.9542,298.05
Gross Profit Growth
-+14.37%+9.19%
Gross Profit Margin %
66.11%69.35%70.47%
Other Operating Expenses, Total
31,073.4835,059.9939,025.16
Other Operating Expenses, Total Growth
R&D Expenses
Selling General & Admin Expenses
Other Operating Expenses
-+12.83%+11.31%
1,756.961,943.012,059.69
28,782.1132,609.2436,539.83
287.89302.34279.95
Operating Income
2,796.23,677.963,272.89
Operating Income Growth
-+31.53%-11.01%
EBIT Margin %
5.46%6.58%5.45%
Net Interest Expenses
179.63174.43272.3
Net Interest Expenses Growth
--2.89%+56.11%
Interest Expense, Total
-18.53-12.26-29.22
Interest And Investment Income
198.16186.69301.52
Other Non Operating Expenses, Total
148.59214.96-3,891.63
EBT, Excl. Unusual Items
3,124.414,067.34-346.44
Gain (Loss) On Sale Of Assets
0.079.545.98
Other Unusual Items, Total
--23.8-
EBT, Incl. Unusual Items
3,422.84,353.1848.52
EBT, Incl. Unusual Items Growth
-+27.18%-98.89%
EBT, Incl. Unusual Items Margin
6.68%7.79%0.08%
Income Tax Expense
453.53830.99803.41
Net Income to Company
2,969.273,522.2-754.89
Minority Interest
---
Net Income
2,969.273,522.2-754.89
Net Income Growth
-+18.62%-121.43%
Net Income Margin %
5.8%6.31%-1.26%
Preferred Dividend and Other Adjustments
---
Net Income to Common Excl. Extra Items
2,969.273,522.2-754.89
Basic EPS - Continuing Operations
423501-99.5
Basic EPS - Continuing Operations Growth
-+18.44%-119.86%
Diluted EPS - Continuing Operations
423501-99.5
Diluted EPS - Continuing Operations Growth
-+18.44%-119.86%
Basic Weighted Average Shares Outstanding
7.027.037.59
Diluted Weighted Average Shares Outstanding
7.027.037.59
Dividend Per Share
---
Dividend Per Share Growth
---
EBITDA
4,074.215,029.134,648.55
EBITDA Growth
-+23.44%-7.57%
EBITDA Margin %
7.95%9%7.74%
EBIT
2,796.23,677.963,272.89
* In Millions of KRW (except for per share items)

FAQ

What was Samik Pharm’s revenue at year end?

At the end of the last reported fiscal year, Samik Pharm (014950) recorded total revenue of 60,020 million KRW.

How much revenue did Samik Pharm report in the most recent quarter?

In its most recent quarterly earnings report, Samik Pharm posted revenue of 15,702 million KRW.

What was Samik Pharm’s net income for the year?

For the full year, Samik Pharm reported net income of -755 million KRW.

How much net income did Samik Pharm post in the last quarter?

In the most recent quarter, Samik Pharm (014950) posted net income of -77 million KRW.

What was Samik Pharm’s gross profit for the year?

Gross profit for the year was reported at 42,298 million KRW.

How much gross profit did Samik Pharm generate last quarter?

Samik Pharm recorded gross profit of 10,520 million KRW in its latest quarterly report.

What was Samik Pharm’s annual operating income?

For the full year, Samik Pharm (014950) reported operating income of 3,273 million KRW.

What was Samik Pharm’s operating income last quarter?

Quarterly operating income was -228 million KRW.

What was Samik Pharm’s quarterly EBITDA?

In the latest quarter, EBITDA was reported at 92 million KRW.

What was the quarter-over-quarter change in EBITDA for Samik Pharm?

EBITDA changed by -93% million KRW compared to the last quarter.

What is Samik Pharm’s most recent gross profit margin?

The latest reported gross profit margin for Samik Pharm (014950) is 67% million KRW.

What is Samik Pharm’s most recent net income margin?

Net income margin based on recent financials is -0% million KRW.

What is Samik Pharm’s most recent EBIT margin?

Samik Pharm reported an EBIT margin of -1% million KRW based on current figures.

How did Samik Pharm’s revenue change compared to the previous quarter?

Revenue changed by 1% million KRW compared to the prior quarter.

What was the quarter-over-quarter change in gross profit for Samik Pharm?

In the latest quarter, gross profit changed by -4% million KRW from the previous quarter.
Install Our App
Follow us
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.